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Abstract
Aim: ABCA1 protects against atherosclerosis by facilitating cholesterol efflux from macrophage foam cells in the arterial wall
to extracellular apolipoprotein (apo) A-I. In contrast to apoA-I, apoE is secreted by macrophages and can, like apoA-I, induce
ABCA1-mediated cholesterol efflux. Yet, the combined effect of macrophage ABCA1 and apoE on lesion development is
unexplored.
Methods and Results: LDL receptor knockout (KO) mice were transplanted with bone marrow from ABCA1/apoE double KO
(dKO) mice, their respective single KO’s, and wild-type (WT) controls and were challenged with a high-fat/high-cholesterol
diet for 9 weeks. In vitro cholesterol efflux experiments showed no differences between ABCA1 KO and dKO macrophages.
The serum non-HDL/HDL ratio in dKO transplanted mice was 1.7-fold and 2.4-fold (p,0.01) increased compared to WT and
ABCA1 KO transplanted mice, respectively. The atherosclerotic lesion area in dKO transplanted animals (650694610
3 mm
2),
however, was 1.9-fold (p,0.01) and 1.6-fold (p,0.01) increased compared to single knockouts (ABCA1 KO:
341620610
3 mm
2;a p o EK O :4 0 2 678610
3 mm
2, respectively) and 3.1-fold increased (p,0.001) compared to WT
(211620610
3 mm
2). When normalized for serum cholesterol exposure, macrophage ABCA1 and apoE independently
protected against atherosclerotic lesion development (p,0.001). Moreover, hepatic expression levels of TNFa and IL-6 were
highly induced in dKO transplanted animals (3.0-fold; p,0.05, and 4.3-fold; p,0.001, respectively). In agreement, serum IL-6
levels were also enhanced in ABCA1 KO transplanted mice (p,0.05) and even further enhanced in dKO transplanted animals
(3.1-fold as compared to ABCA1 KO transplanted animals; p,0.05).
Conclusions: Combined deletion of macrophage ABCA1 and apoE results in a defect in cholesterol efflux and, compared to
ABCA1 KO transplanted mice, elevated serum total cholesterol levels. Importantly, these mice also suffer from enhanced
systemic and hepatic inflammation, together resulting in the observed augmented atherosclerotic lesion development.
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Introduction
Accumulation of cholesterol in macrophages leads to the
formation of foam cells, a crucial event in the development of
atherosclerotic lesions. Because macrophages are incapable of
limiting the uptake of lipoproteins, these cells rely on reverse
cholesterol transport (RCT) for maintaining cellular cholesterol
homeostasis [1,2]. We have shown that apolipoprotein (apo) E as
well as the ATP-binding cassette (ABC) transporters A1 and G1
are key players in the efflux of cholesterol from macrophages, the
first step in RCT and protection against atherosclerosis [3,4,5].
ABCA1 facilitates cholesterol efflux to lipid-poor apolipoproteins
[6] like apoA-I, resulting in the formation of lipidated HDL.
Subsequently, ABCG1 mediates the efflux of cellular cholesterol to
these mature HDL particles [7,8]. In addition, ABCA1 can
modulate the secretion of apoE [9]. Secreted apoE by macro-
phages facilitates cellular cholesterol efflux [10] both in the
presence and absence of extracellular cholesterol acceptors [11].
Although both pro- and anti-atherogenic functions for macro-
phage apoE have been described [12,13,14,15], we recently
showed that macrophage apoE protects against atherosclerotic
lesion development, independent of ABCG1 [5] in LDL receptor
knockout (LDLr KO) mice. Moreover, very recently, Zanotti et al.
showed that expression of apoE only in macrophages is sufficient
to promote RCT, emphasizing the pivotal anti-atherogenic role
for macrophage apoE [16]. Importantly, macrophage apoE-
mediated cholesterol efflux was shown to be independent of
ABCA1 in apoE expressing J774 macrophages [17], suggesting
that the atheroprotective effects of macrophage ABCA1 are
independent of apoE production by macrophages. However, in
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it was shown that apoE secretion from macrophages is promoted
by ABCA1 [9].
To investigate the possible interaction between ABCA1 and
apoE in promoting macrophage cholesterol efflux and their
combined roles in atherogenesis, we generated mice deficient for
both ABCA1 and apoE and performed a bone marrow
transplantation (BMT) experiment in LDLr KO mice. Our results
evidently show that transplantation of LDLr KO mice with either
ABCA1 KO or apoE KO bone marrow resulted in a moderate
increase in atherosclerotic lesion development, while combined
deletion of ABCA1 and apoE in bone marrow-derived cells led to
a more dramatic increase in atherosclerosis.
Methods
Animals and Bone Marrow Transplantation
ABCA1 KO [18] and apoE KO (The Jackson Laboratory, Bar
Harbor, ME) mice (both more than 7 times backcrossed onto a
C57BL/6J background) were mated to generate F1 heterozygotes.
Heterozygote F1 animals were crossbred to obtain ABCA1
2/2/
apoE
+/+ (ABCA1 KO), ABCA1
+/+/apoE
2/2 (apoE KO),
ABCA1
2/2/apoE
2/2 (dKO), and ABCA1
+/+/apoE
+/+ (WT)
mice, which were used as donors for the bone marrow
transplantation. These donor mice were anaesthetized subcutane-
ously with a mix of 70 mg/kg body weight xylazine, 1.8 mg/kg
bodyweight atropine and 350 mg/kg body weight ketamine.
Animals were subsequently sacrificed by cervical dislocation. Bone
marrow cells were then isolated from the femurs and tibias from
these mice. Homozygous C57BL/6J LDL receptor knockout
(LDLr KO) mice were obtained from The Jackson Laboratory as
mating pairs and bred at the Gorlaeus Laboratory, Leiden, The
Netherlands. Bone marrow transplantations to male LDLr KO
mice were performed as described [19]. Briefly, irradiated
recipients ($11 per group) received 5610
6 bone marrow cells by
intravenous injection into the tail vein. After a recovery period of 8
weeks, the animals were challenged with a high-fat/high-
cholesterol (HF/HC; 1.25% cholesterol, 21% fat (Abdiets,
Woerden, the Netherlands)) diet for 9 weeks to induce atheroscle-
rotic lesion development. At 17 weeks after transplantation, mice
were anaesthetized subcutaneously with a mix of 70 mg/kg body
weight xylazine, 1.8 mg/kg bodyweight atropine and 350 mg/kg
body weight ketamine. Animals were subsequently sacrificed by
cervical dislocation. The hematologic chimerism of the trans-
planted LDLr KO mice was confirmed in genomic DNA from
bone marrow by PCR analysis (Fig. 1). Animal experiments were
approved by the Ethics Committee for Animal Experiments of
Leiden University (permit number 08015) and performed at the
Gorlaeus Laboratories of the Leiden/Amsterdam Center for Drug
Research in accordance with the National Laws and the Directive
2010/63/EU of the European Parliament.
Histological Analysis of the Aortic Root, Aortic Arch, and
Spleen
To analyze the development of atherosclerosis at the aortic root
and aortic arch, transplanted LDLr KO mice were euthanized
after 9 weeks of feeding the HF/HC diet. The arterial tree was
perfused in situ with PBS (100 mm Hg) for 10 min via a cannula
in the left ventricular apex. The heart plus aortic root and the
aortic arch were excised and stored in 3.7% neutral-buffered
formalin (Formal-fixx; Shandon Scientific Ltd, Runcorn, UK).
Serial sections (10 mm) of the aortic root were cut using a Leica
CM3050S cryostat. The atherosclerotic lesion areas in oil red-O
stained cryostat sections of the aortic root and whole aortic arches
were quantified using the Leica image analysis system, consisting
of a Leica DMRE microscope coupled to a video camera and
Leica Qwin Imaging software (Leica Ltd, Cambridge, UK). Mean
lesion area (in mm
2) was calculated from 10 consecutive oil red-O
stained sections of the aortic root, starting at the appearance of the
tricuspid valves. Sections were stained immunohistochemically for
the presence of macrophages using a rat MOMA-2 antibody,
dilution 1:50 (Serotec Ltd, Oxford, UK). Goat anti-rat coupled to
horse radish peroxidase (HRP) (1:100) (Dako, Glostrup, Denmark)
was used as a secondary antibody and Nova red substrate (Vector
Laboratories, Burlingame, California) was used for visualization of
HRP. Collagen content of the plaques was determined after
Masson’s Trichrome staining (Sigma Diagnostics, St Louis, MO,
USA). Relative plaque area in the aortic arch was quantified en face
calculating the ratio of atherosclerotic lesions to the surface of the
entire aortic arch. In addition, 7 mm cryosections of formalin-fixed
spleen from the transplanted LDLr KO mice were prepared and
stained for lipid accumulation using oil red-O and counterstained
with hematoxylin.
Lipid Analyses
Eight weeks after bone marrow transplantation, 100 mLo f
blood was drawn from each individual mouse by tail bleeding after
an overnight fasting period. Upon sacrifice, 17 weeks after bone
marrow transplantation, blood was collected by retro-orbital
Figure 1. Successful disruption of macrophage ABCA1 and apoE by bone marrow transplantation. RT-PCR on genomic DNA of bone
marrow isolated from ABCA1 and/or apoE KO transplanted LDLr KO mice and their WT transplanted controls at 17 weeks after transplantation.
doi:10.1371/journal.pone.0026095.g001
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analyses were performed as described [19].
Lipoprotein profiles from all mice were determined by
fractionation of 50 mL samples of serum, pooled from 2 mice
per genotype, using a Superose 6 column (3.26300 mm, Smart-
System; Pharmacia, Uppsala, Sweden). Total cholesterol (TC)
content of the effluent was determined as described [19], and
calculated as a percentage of serum TC. Splenic free cholesterol
(FC), cholesteryl ester (CE) and triglyceride (TG) content were
determined as described [19] after extraction according to Bligh
and Dyer [20] and dissolving the lipids in 2% Triton X-100. ApoE
Western blot analysis of pooled VLDL and LDL fractions was
performed by running equal amounts of total cholesterol per
lipoprotein (VLDL: 3.8 mg, LDL: 4.6 mg) on a 15% SDS-PAGE
gel. ApoE was detected using a rabbit-anti-mouse apoE polyclonal
antibody (SB Rabbit 67-AH). As a secondary antibody a goat-anti-
rabbit IgG-HRP (Jackson ImmunoResearch, Suffolk, UK) was
used.
Cellular Cholesterol Efflux
For isolation of bone marrow-derived macrophages (BMDM),
femurs and tibias were lavaged with PBS. Bone marrow cells were
plated in DMEM/20% FCS/1% penicillin/1% streptomycin and
differentiated into macrophages by addition of 30% L929 cell-
conditioned media (as a source of M-CSF) for 7 days.
Subsequently, BMDM were incubated with 0.5 mCi/mL
3H-
cholesterol in DMEM/0.2% fatty acid free BSA and 30 mg/mL
non-labeled cholesterol for 24 h at 37uC. Cholesterol efflux was
determined after incubating the cells in DMEM/0.2% fatty acid
free BSA in the absence or presence of 10 mg/mL apoAI
(Calbiochem, La Jolla, CA, USA) or 50 mg/mL human HDL,
isolated according to Redgrave et al. [21]. Radioactivity in the
medium and the cells was determined by scintillation counting
after 24 h of incubation. Cholesterol efflux is expressed as the
percentage of total cell
3H-cholesterol present in the medium after
24 h. Basal efflux to BSA (in the absence of ApoA-I and HDL) has
been subtracted from the data shown.
mRNA Expression Analysis by Real Time PCR
Total RNA from BMDM was isolated using the guanidinium
thiocyanate (GTC) method [22] and reverse transcribed using a
RevertAid M-MuLV enzyme (Fermentas, Burlington, Canada).
Relative mRNA expression was measured from the following
genes: scavenger receptor class B type I (SR-BI), LDL receptor-
related protein 1 (LRP1), 3-hydroxy-3-methyl-glutaryl-CoA re-
ductase (HMG-CoA reductase), microsomal triglyceride transfer
protein (MTP), ATP-binding cassette transporter sub-family G
member 1 (ABCG1), apolipoprotein (apo) B and E, lipoprotein
lipase (LPL), fatty acid synthase (FAS), interleukin 6 (IL-6), tumor
necrosis factor a (TNFa), and diacylglycerol acyltransferase-1
(DGAT-1). The mRNA expression levels were assessed by real
time PCR (ABI PRISM 7500; Applied Biosystems, Foster City,
CA) using SYBR Green technology (Applied Biosystems).
Housekeeping genes RPS13, 36B4, and HPRT were used as a
control. Primer sequences are available upon request.
Determination of Serum Cytokine Concentrations
Murine IL-6 and IFNc serum levels were assayed using an
instant ELISA kit (eBioscience, Hatfield, UK) according to the
manufacturer’s protocol. Murine IL-10 and TNFa serum levels
were assayed using an instant ELISA kit (BD Biosciences,
Erembodegem, Belgium) according to the manufacturer’s
protocol.
Statistical Analysis
Statistically significant differences among the means of the
different populations were tested using analysis of variance
(ANOVA) and when specifically indicated the unpaired Student’s
t-test (GraphPad InStat and Prism software). The Student-
Newman-Keuls multiple comparison test was performed after
ANOVA. Two-way ANOVA was used to check possible
interactions. The probability level (alpha) for statistical significance
was set at 0.05. Results are expressed as an average 6 SEM.
Results
Shift Toward a More Pro-Atherogenic Lipoprotein Profile
in ABCA1/apoE dKO Transplanted LDLr KO Mice
Cholesterol levels were measured at 8 weeks (chow diet) and at
17 weeks (HF/HC diet, containing 1.25% cholesterol and 21%
fat) after BMT (Table 1). On chow diet, free cholesterol (FC) levels
were moderately increased in apoE KO transplanted mice (15%,
p,0.01). However, no effect of ABCA1 and/or apoE deletion in
bone marrow-derived cells was observed on serum total cholesterol
(TC) levels. After 9 weeks of feeding the HF/HC diet, serum
cholesterol levels of the control mice and the apoE KO
transplanted mice increased <3-fold. However, in agreement
with previous studies [3,23], deletion of ABCA1 in bone marrow
cells resulted in an attenuated 1.7-fold increase in plasma TC
levels upon feeding an atherogenic diet compared to WT controls
(p,0.001). Importantly, although ABCA1/apoE dKO transplant-
ed mice still exhibited an attenuated rise in TC levels compared to
WT controls (2.4-fold; p,0.01), these levels were significantly
higher compared to levels of ABCA1 KO transplanted mice (1.4-
fold; p,0.05).
The distribution of TC among serum lipoproteins was analyzed
by liquid chromatography (Fig. 2). The observed decrease in
cholesterol levels of ABCA1 KO transplanted mice upon feeding
the HF/HC diet was mainly caused by a 54% decrease in
cholesterol associated with VLDL and LDL (non-HDL-C;
p,0.001; Table 1). However, HDL-C levels in these mice were
only reduced by 32%, which resulted in a decreased non-HDL/
HDL ratio (Table 1). In contrast, the non-HDL/HDL ratio of
apoE KO transplanted mice was increased compared to WT
controls (1.7-fold; Table 1), since HDL-C was reduced by 34%
(p,0.05; Table 1), whereas non-HDL-C levels remained stably
high. In agreement with ABCA1 KO transplanted mice, non-
HDL-C of apoE/ABCA1 dKO transplanted animals was reduced
compared to WT controls (30%; p,0.05; Table 1). However, also
a dramatic 52% reduction was observed in HDL-C levels of these
mice (p,0.001; Table 1), which resulted in an increased non-
HDL/HDL ratio (2.4-fold; p,0.01 compared to ABCA1 KO;
Table 1), suggesting a more pro-atherogenic index.
No Differences in Serum VLDL/LDL ApoE Concentrations
after HF/HC Diet Feeding
ApoE is essential for clearance of lipoproteins from the
circulation via the LDLr or LDL-receptor-related protein
(LRP1). To investigate if normalization of the HF/HC diet-
induced increase in VLDL/LDL is the consequence of a lower
apoE content on these particles, apoE was determined in the
lipoprotein fractions by Western blotting and normalized for
cholesterol in the fractions (Fig. 3)
No apparent differences were observed in the apoE content of
VLDL and LDL between the different groups of mice, indicating
that disruption of apoE production by bone marrow-derived cells
does not impair the availability of apoE on the particles for
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Increased Lipoprotein Lipase mRNA Expression in Liver
In order to further investigate the possible mechanisms
regarding the observed differences in serum TC levels, we
quantified mRNA expression levels of key liver enzymes in fatty
acid and triglyceride synthesis (FAS and DGAT-1, respectively),
cholesterol efflux (ABCG1) and synthesis (HMG-CoA reductase),
apolipoproteins (apo) B and E, and genes involved in lipoprotein
assembly (MTP) and uptake (SR-BI, LRP1), but found no
differences. However, hepatic lipoprotein lipase (LPL) expression
was 1.9-fold increased in ABCA1 KO transplanted animals as
compared to dKO transplanted animals (p,0.05). LPL is essential
for the lipolysis of lipoproteins. Induction of LPL leads to rapid
clearance of VLDL and chylomicrons. Therefore, the observed
attenuation of LPL expression in the dKO transplanted mice
might have contributed to the increased TC levels as compared to
ABCA1 KO transplanted animals.
Enlarged, Cholesteryl Ester Enriched Spleens in ABCA1/
apoE dKO Transplanted Mice
Upon sacrifice (17 weeks after BMT; 9 weeks HF/HC diet
feeding), spleens from all mice were examined. While both single
KO transplanted groups showed no differences in spleen weight
compared to WT controls, spleens from dKO transplanted
animals were enlarged by 39% (p,0.001; Fig. 4). To further
investigate this, spleen sections were stained with oil red-O to
visualize lipid accumulation. No apparent staining was visible in
spleens from WT controls and apoE KO transplanted mice, while
spleens from ABCA1 KO transplanted mice stained mildly for
lipids (Fig. 4). In contrast, mice transplanted with ABCA1/apoE
Table 1. Serum lipid and lipoprotein levels were measured at 8 weeks (chow diet) and 17 weeks (HF/HC diet) after transplantation.
Donor BM Time (wks) Diet FC (mg/dL) TC (mg/dL) Non-HDL-C (mg/dL) HDL-C (mg/dL) Non-HDL/HDL ratio
WT 8 Chow 81623 1 7 615 n.d n.d n.d
17 HF/HC 267614 1021675 929689 92611 1061
ABCA1 KO 8 Chow 75652 9 4 615 n.d n.d n.d
17 HF/HC 148613*** 493641*** 430656*** 6365** 761
apoE KO 8 Chow 9363** 323614 n.d n.d n.d
17 HF/HC 303617 1030684 969667 6165* 1763
##
dKO 8 Chow 83632 9 4 613 n.d. n.d n.d
17 HF/HC 216618*
## 691666**
# 6476106* 4467*** 1764
##
Data represent mean 6 SEM of $10 mice.
*p,0.05,
**p,0.01,
***p,0.001 compared to WT;
#p,0.05,
##p,0.01 compared to ABCA1 KO; n.d.=not determined.
doi:10.1371/journal.pone.0026095.t001
Figure 2. Lipoprotein profiles from ABCA1 and/or apoE KO transplanted LDLr KO mice and their WT transplanted controls. Fifty mL
samples of serum, pooled from 2 mice per genotype, collected after 9 weeks of HF/HC feeding, were subjected to FPLC fractionation. Distribution of
serum FC and TC over the fractions (25 mL) was determined enzymatically. Values represent the means of n$5 samples per group. 1 sample
corresponds to pooled serum of 2 mice.
doi:10.1371/journal.pone.0026095.g002
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predominantly in the red pulp, explaining the large increase in
size. To further investigate the splenic lipid composition, we
isolated the lipid content and measured FC, CE and TG levels. In
agreement with the lipid accumulation visualized by oil red-O
staining, spleens from dKO transplanted mice revealed a 3.0-fold
(p,0.01; Figure 4B) increase in CE levels. FC and TG content of
these spleens were not significantly different. No lipid accumula-
tion was observed in other tissues.
Increased Atherosclerosis in ABCA1/apoE dKO
Transplanted LDLr KO Mice
After feeding the HF/HC diet for 9 weeks, lesion development
in the aortic root and the aortic arch of the transplanted animals
was analyzed. En face quantification of the aortic arch lesions
revealed a 2.5-fold increased lesion area in single KO transplanted
mice compared to WT controls (p,0.01; WT: 962%, ABCA1
KO: 2363%, apoE KO: 2261%) and a striking 3.8-fold increase
in dKO transplanted animals (p,0.01; dKO: 3465%; Fig. 5). In
agreement, quantification of the lesion sizes in oil red-O stained
sections of the aortic root showed that single deletion of
macrophage ABCA1 or apoE led to a 1.6- or 1.9-fold increase
in the mean atherosclerotic lesion size, respectively, compared to
lesions in WT transplanted animals (341620610
3 mm
2 in mice
reconstituted with ABCA1 KO bone marrow and
402678610
3 mm
2 in animals transplanted with apoE KO bone
marrow, compared to 211620610
3 mm
2 in mice reconstituted
with WT bone marrow; Fig. 6A). This however failed to reach
statistical significance by ANOVA. As the current study consisted
of four groups, ANOVA is the appropriate test to check for
significant differences. Previous studies [3,12,13], however, used
two groups (WT vs. KO), which only required a t-test. When the
same t-test is used, both ABCA1 KO and apoE KO transplanted
animals showed a significant increase in atherosclerotic lesion size
compared to mice reconstituted with WT bone marrow (p,0.001
and p=0.042, respectively). Combined deletion of both ABCA1
and apoE in bone marrow-derived cells in LDLr KO mice
induced a significant 3.1-fold (p,0.001; ANOVA) increase in the
mean atherosclerotic lesion size compared to WT transplanted
animals (650694610
3 mm
2 compared to 211620610
3 mm
2). In
Figure 3. ApoE protein content in VLDL and LDL fractions from
ABCA1 and/or apoE KO transplanted LDLr KO mice and their
WT transplanted controls. Western blots showing apoE protein
expression in VLDL (A) and LDL (B) isolated from ABCA1 KO and/or apoE
KO transplanted LDLr KO animals and WT transplanted controls after
feeding the HF/HC diet for 9 weeks. Samples were adjusted for
cholesterol content. The density of the bands was determined using
quantification software (Image J). n$5 samples per group (pooled). WT
values were set at 100%.
doi:10.1371/journal.pone.0026095.g003
Figure 4. Increased CE content in enlarged spleens from ABCA1/apoE dKO transplanted LDLr KO mice. Representative cross sections of
spleens from the bone marrow transplanted LDLr KO mice stained with oil red-O for the detection of neutral lipids and counterstained with
hematoxylin (magnification 506; upper panels). Spleen weight to bodyweight ratio is increased in ABCA1/apoE dKO transplanted LDLr KO mice (A).
Values represent the means of n$11 mice 6 SEM per group. Quantification of cholesteryl ester (CE) and free cholesterol (FC) content of spleens (B
and C, respectively). Values represent the means of n$5 mice 6 SEM per group. **p,0.01, ***p,0.001 as compared to WT transplanted controls.
doi:10.1371/journal.pone.0026095.g004
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significantly larger compared to mice transplanted with single
ABCA1 KO or apoE KO bone marrow (1.9- and 1.6-fold,
respectively; p,0.01; ANOVA).
No differences in macrophage content in the aortic root plaques
were observed (WT: 143619610
3 mm
2, ABCA1 KO: 136619
610
3 mm
2, apoE KO: 198627610
3 mm
2, dKO: 1396216
10
3 mm
2). As expected, the collagen content was significantly
increased in plaques from dKO transplanted mice, indicating
more advanced lesions (p,0.01 to single KO transplanted mice
and WT controls (WT: 3.361.2610
3 mm
2, ABCA1 KO: 6.86
1.8610
3 mm
2, apoE KO: 3.660.8610
3 mm
2, dKO: 2669.36
10
3 mm
2).
Interestingly, although single deletion of macrophage ABCA1
or apoE showed a comparable increase in atherosclerotic lesion
development, TC levels between these groups were dramatically
different (Fig. 6A). In humans, TC levels are correlated with
atherosclerosis and are therefore a widely accepted risk factor for
atherosclerotic disease [24]. To adjust for cholesterol exposure, we
divided the atherosclerotic lesion size by TC concentrations
(Fig. 6B). As a result, the corrected atherosclerotic lesion size of
ABCA1 transplanted mice was 3.1-fold increased compared to
WT controls, underscoring the important anti-atherogenic role for
macrophage ABCA1 in atherosclerotic lesion development.
Furthermore, since TC levels did not differ between apoE KO
transplanted mice and WT controls, the corrected lesion size also
showed a similar anti-atherogenic role for macrophage apoE.
Importantly, dKO transplanted mice displayed a 4.3-fold
increased lesion development compared to WT controls after
TC adjustment.
Figure 5. Analysis of atherosclerosis in the aortic arch of bone marrow transplanted LDLr KO mice after 9 weeks of HF/HC diet
feeding. Relative plaque area in the aortic arch was quantified en face calculating the ratio of atherosclerotic lesions to the surface of the entire
aortic arch (left panel). Representative pictures (right panels). **P,0.01 as compared to WT transplanted controls.
doi:10.1371/journal.pone.0026095.g005
Figure 6. Analysis of atherosclerosis in the aortic root of bone marrow transplanted LDLr KO mice after 9 weeks of HF/HC diet
feeding. Quantification of atherosclerotic lesion sizes in the aortic root and TC levels in bone marrow transplanted LDLr KO mice after 9 weeks of HF/
HC diet feeding (A). Lesion size divided by TC levels show cholesterol independent effects on lesion development (B). Representative cross-sections,
stained with oil red-O (magnification 506; lower panels).Values are the means of 10 aortic root sections of individual mice (n$11 mice 6 SEM per
group. **p,0.01, ***p,0.001 as compared to WT transplanted controls,
#p,0.05 as compared to ABCA1 KO transplanted animals.
doi:10.1371/journal.pone.0026095.g006
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atherosclerotic lesion development, independent of effects on TC
levels, two-way ANOVA was used on the corrected atherosclerosis
data to analyze possible interactions between macrophage ABCA1
and apoE expression. The regular P value was used to express the
significance of the effect of apoE deletion on ABCA1 and vice
versa, whereas the interaction P value shows the independent
effects of both genes on atherosclerotic lesion development. This
test showed highly independent effects of ABCA1 or apoE deletion
in bone marrow-derived cells on atherosclerotic lesion formation
(Fig. 6B). The apoE gene accounted for 10% of the variation
(p=0.0008), whereas the ABCA1 gene contributed 59% to the
total variation (p,0.0001). In agreement, no interaction (p=0.37)
was observed, suggesting that single deletion of ABCA1 or apoE
induces atherosclerosis, independent of cholesterol levels. More-
over, atherosclerotic lesion development in dKO transplanted
mice is an additive, independent effect of the single deletions of
ABCA1 and apoE.
In Vitro Cellular Cholesterol Efflux
Combined deletion of macrophage ABCA1 and apoE resulted
in a significant increase in atherosclerotic lesion development.
Moreover, spleens of these mice were significantly enlarged and
enriched in CE content. To determine whether these effects were
caused by a defect in the ability to transport cholesterol out of the
cells to exogenous lipid acceptors, an in vitro cholesterol efflux assay
to BSA, apoA-I, and HDL was performed. In line with previous
results [5], deletion of macrophage apoE resulted in an impaired
cholesterol efflux to BSA (41%, p,0.001; Fig. 7A) emphasizing its
ability to promote the efflux of cellular cholesterol in the absence
of extracellular acceptors. Similarly, a 35% decreased cholesterol
efflux to BSA was observed with ABCA1 KO and dKO cells
(p,0.001). As expected, cholesterol efflux to apoA-I was
completely inhibited when macrophages lacking ABCA1 were
used (p,0.001; Fig. 7B). ABCA1 KO macrophages also exhibited
a 47% decreased efflux capacity to HDL (p,0.001; Fig. 7C). In
agreement with previous data [5,12], deficiency of apoE in
macrophages resulted in a small but significant decrease in
cholesterol efflux to both apoA-I (16%, p,0.001), and HDL (21%;
p,0.001). However, surprisingly, no additional effect of apoE
deficiency was observed on cholesterol efflux to HDL in the
absence of macrophage ABCA1, suggesting that efflux induced by
endogenously produced apoE requires ABCA1 expression. It also
indicates that the enlarged lipidated spleen and the enhanced
atherosclerotic lesion development specifically observed in dKO
transplanted mice cannot be explained by additional effects on the
cholesterol efflux mechanisms.
Increased Expression of Hepatic and Systemic Pro-
Inflammatory Cytokines
In order to further investigate the possible mechanisms
regarding the increased atherosclerotic lesion development in
ABCA1/apoE dKO transplanted mice, we quantified mRNA
expression levels of the inflammatory molecules TNFa and IL-6 in
the liver. Surprisingly, we found highly increased TNFa (3.0-fold;
p,0.05; Figure 8A) and IL-6 (4.3-fold; p,0.001; Figure 8B)
expression levels, indicating an enhanced inflammatory status of
these animals. In addition, we analyzed both pro- and anti-
inflammatory cytokines in the circulation, including TNFa, IFNc,
IL-6 and IL-10. Whereas TNFa, IFNc, and IL-10 concentrations
were too low to be detected in the serum of these animals, a major
increase in the secretion of the pro-inflammatory cytokine IL-6 in
ABCA1 KO transplanted animals was observed (p,0.05;
Figure 8C), which was even further enhanced in dKO transplant-
ed animals (3.1-fold as compared to ABCA1 KO transplanted
animals; p,0.05). Serum IL-6 is generally considered a systemic
inflammatory marker. As a result, the observed elevated IL-6 levels
indicate an intensified inflammatory environment which, at least
partly, contributed to the observed increase in atherosclerotic
lesion development.
Discussion
Although the functions of macrophage ABCA1 and apoE in the
development of atherosclerosis have been studied extensively
[3,4,5,12,13,14,15], their potential combined role in atheroscle-
rotic lesion development is still unexplored. In the present study,
we show that macrophage ABCA1 and apoE independently
protect against atherosclerotic lesion formation, when normalized
for serum cholesterol exposure.
ABCA1 is known to facilitate cholesterol efflux to lipid-poor
apolipoproteins [6]. As a result, cholesterol efflux to apoA-I was
Figure 7. In vitro cellular cholesterol efflux. Cholesterol efflux from
bone marrow-derived macrophages (BMDM) to BSA (A), apoA-I (10 mg/
mL; B) and HDL (50 mg/mL; C) was determined after 24 h. Data are
expressed as the percentage of radioactivity released into the medium.
Values represent the means of n$3 mice 6 SEM per group. ***p,0.001
as compared to WT transplanted controls.
doi:10.1371/journal.pone.0026095.g007
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Macrophages do not produce apoA-I, but, apoE secreted by
macrophages [10] is able to induce efflux of cholesterol both in the
presence and absence of extracellular cholesterol acceptors (e.g.
ApoA-I or HDL) [11], which is confirmed in this study.
Interestingly, no added effect on cholesterol efflux was observed
in dKO macrophages compared to ABCA1 deficient macrophag-
es, indicating that endogenously produced apoE requires ABCA1
to facilitate cholesterol efflux.
Nonetheless, spleens of ABCA1/apoE dKO transplanted mice
were enlarged due to severe CE accumulation. In agreement with
the current study, several publications have shown increased lesion
development in ABCA1 KO transplanted mice, despite a clear
reduction in serum cholesterol levels [3,23,25]. Interestingly, TC
levels in serum were markedly increased upon combined deletion
of macrophage ABCA1 and apoE as compared to single deletion
of ABCA1 in macrophages. This thus leads to ABCA1 deficiency –
a defect in cholesterol efflux – combined with elevated serum total
cholesterol levels. Therefore, the observed enlargement and CE
accumulation of spleens from dKO transplanted mice are most
likely the result of enhanced lipid uptake due to the increased TC
pressure from the circulation. In agreement with this hypothesis,
less lipid accumulation and no changes in spleen size were
observed in single KO transplanted animals.
In the current study, transplanted LDLr KO mice were fed a
HF/HC diet for 9 weeks to induce increased serum cholesterol
levels. A minimum serum cholesterol concentration of .300 mg/
dL is required for the development of experimental atheroscle-
rosis in LDLr KO mice [26]. Single deletion of macrophage
ABCA1 or apoE led to a comparable increase of atherosclerotic
lesion development. However, circulating TC levels were over 2-
fold higher in apoE KO transplanted animals compared to
ABCA1 KO transplanted mice. Accordingly, although the
absolute lesion size did not differ between both genotypes, the
lesions adjusted for serum total cholesterol exposure showed the
high relative importance of ABCA1 deficiency for determining
atherosclerosis susceptibility. Strikingly, despite the fact that
single macrophage apoE deficiency did not alter serum TC
concentrations, dKO transplanted mice had significantly higher
TC levels than single macrophage ABCA1 KO transplanted
animals.
We previously found that circulating apoE levels can be
influenced by macrophage ABCA1 deficiency [3]. In addition,
ABCA1 was shown to promote macrophage apoE secretion in
primary human monocyte-derived macrophages and THP-1 cells
[9]. However, in the present study, the amount of apoE on VLDL
and LDL particles was not reduced upon transplantation of apoE
or ABCA1 deficient bone marrow into LDLr KO mice, indicating
no direct quantitative effects of macrophage ABCA1 deficiency on
apoE availability.
To get insight into the mechanisms behind the altered TC
levels, key genes involved in lipoprotein metabolism were analysed
in liver. Of all genes analysed only LPL was found to be
differentially expressed in liver. Therefore, it is tempting to
speculate that the lower serum TC levels in ABCA1 KO
transplanted animals might be the result of the observed increase
in hepatic LPL expression levels. LPL is essential for the lipolysis of
lipoproteins. Induction of LPL leads to rapid clearance of VLDL
and chylomicrons [27]. Therefore, the observed attenuation of
LPL expression in the dKO transplanted mice as compared to
ABCA1 KO transplanted animals might have contributed to the
increased TC levels.
Besides the general significance of serum TC levels, the
distribution over the different lipoproteins in the circulation can
vary greatly, thereby changing its impact on atherosclerotic lesion
development. Non-HDL is considered to have a pro-atherogenic
function, whereas HDL – involved in RCT – acts as an anti-
atherogenic lipoprotein [2,28,29]. Serum lipoprotein distribution
analysis revealed that dKO transplanted mice not only showed an
increase in the pro-atherogenic non-HDL cholesterol levels, but
also exhibited a decrease in anti-atherogenic HDL cholesterol
which will probably also have contributed to the enhanced lesion
development in the dKO transplanted animals.
Two-way ANOVA analysis showed that the effects of ABCA1
and apoE on lesion development, when normalized for serum TC
levels, were independent of each other. This is surprising since
apoE can induce cholesterol efflux via ABCA1 and our in vitro
studies using the single and dKO macrophages clearly showed that
ABCA1 is required to induce efflux via endogenously produced
apoE.
Importantly, ABCA1/apoE dKO transplanted mice exhibited a
large induction of the pro-inflammatory cytokines IL-6 and TNFa
Figure 8. Hepatic gene expression levels and circulating IL-6 levels. mRNA expression of TNFa (A), and IL-6 (B) in liver from bone marrow
transplanted LDLr KO mice. Gene expression analysis was performed by RT-PCR. Values are relative to the average expression of housekeeping genes
and expressed as fold induction compared to WT transplanted controls. Values are mean 6 SEM, n$3 mice per group as compared to WT. Increased
circulating IL-6 levels in LDLr KO mice transplanted with ABCA1/apoE double KO bone marrow (C). Serum from the transplanted LDLr KO mice was
collected at 17 weeks after transplantation including 9 weeks of WTD feeding. Values are mean 6 SEM, n$8 mice per group. *p,0.05, **p,0.01.
***p,0.001 as compared to WT transplanted controls.
#p,0.05 as compared to ABCA1 KO transplanted animals.
doi:10.1371/journal.pone.0026095.g008
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increased in these animals, indicating an enhanced inflammatory
status of these animals. The pro-inflammatory cytokine IL-6 is
reported to promote endothelial dysfunction, smooth muscle cell
proliferation and migration as well as recruitment and activation
of inflammatory cells [30]. Moreover, it induces the formation of
macrophage-derived foam cells; a key feature of early and
advanced atherosclerotic lesion formation [31].
In conclusion, LDLr KO mice transplanted with either ABCA1
or apoE KO bone marrow exhibited a distinct increase in
atherosclerosis compared to WT transplanted animals. Impor-
tantly, combined deletion of macrophage ABCA1 and apoE
results in a defect in cholesterol efflux and, compared to ABCA1
KO transplanted mice, elevated serum total cholesterol levels, and
enhanced systemic and hepatic inflammation, together resulting in
the observed augmented atherosclerotic lesion development.
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